BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2331050)

  • 1. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
    Qiu BS; Xu LZ; Kong JC; Chen HL; Tao LD
    Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative analysis of nucleolar organizer regions in nevi and melanomas].
    Dujela N
    Lijec Vjesn; 1993; 115(7-8):241-3. PubMed ID: 8139368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
    Deuble K; McCartney A
    Eye (Lond); 1990; 4 ( Pt 5)():743-50. PubMed ID: 1704315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma.
    Howat AJ; Giri DD; Wright AL; Underwood JC
    J Pathol; 1988 Nov; 156(3):227-32. PubMed ID: 3204453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
    Rebora A
    Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in superficial spreading melanoma with nodule.
    Albrecht S; Jambrosic JA; Kahn HJ
    Mod Pathol; 1989 Nov; 2(6):666-70. PubMed ID: 2587571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
    Fogt F; Vortmeyer AO; Tahan SR
    Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.